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Cefuroxime is a new semi-synthetic cephalosporin with increased resistance to fi-lactamases from Gram negative bacteria. Preliminary investigations have shown it to have a high antimicrobial activity and to be among the best tolerated cephalosporins ( (Freiesleben et al. 1977 ).
The present evaluation was designed to test the susceptibility of both Gram positive and Gram negative bacteria to cefuroxime in comparison to cephalothin. Also, because of the increase of multi-resistant bacteria in hospitals, the effectiveness was examined of combinations of cefuroxime with gentamicin and sisomicin. These results were compared to those of cephalothin -aminoglycoside combinations.
Minimum Inhibitory Concentrations (MIC values) were determined in Mueller-Hinton broth using the tube dilution procedure. To examine the combination effect, a sub-inhibitory concentration of 0.2 Mug of gentamicin or sisomicin was added to each of the geometric dilutions of cefuroxime or cephalothin. The definitions used for addition and synergism were those recommended by Bulger & Kirby (1963) : addition is defined as a reduction of MIC by 1-3 dilutions, and synergy as a reduction of 4 dilutions or more.
Results
Both cefuroxime and cephalothin were highly active against most Gram positive cocci other than the Enterococci. Although on average cephalothin was somewhat more active than cefuroxime, these differences have no clinical significance as Staphylococci and Streptococci had such low MIC values that they were highly sensitive to both cephalosporins.
Cefuroxime was generally more effective than cephalothin against Gram negative bacteria. Table 1 shows the cumulative percentages of the sensitive strains from the different species and also the geometiic means of the MIC values. The most sensitive species tested was Hamophilus influenza of which, at 0.5 ,ug/ml, all the strains were inhibited by cefuroxime and 85 % by cephalothin. The sensitivity of the Proteus species varied widely -when examined in greater detail, P. mirabilis was found to be highly sensitive to both antibitotics, while P. vulgaris was resistant to both. Cefuroxime was active against more strains of both P. morgani and P. retteri than cephalothin. Cefuroxime was shown to be active against all the tested strains of Providencia, while cephalothin was scarcely effective at all. Table 2 shows the activity of the combinations of cefuroxime or cephalothin with gentamicin or sisomicin expressed as cumulative percentages of sensitive strains at the concentrations of 2 and 32 ,g/ml of cephalosporin and as the geometric mean of MIC values. Tables 3 and 4 illustrate the number of additive or synergistic effects of the four combinations against the various species. It is evident that the combination of cefuroxime and sisomicin has proved to be extraordinarly effective against all the species tested.
The resistant strains from 150 isolates of Gram negative bacteria are shown in Table 5 , strains with MIC values above 128 ,ug cephalosporin per ml being resistant. By this criterion cephalothin was ineffective against 58.7 % of the strains tested and cefuroxime against 24.7%. The lowest resistance rate was found with the combination of (Daschner 1975 , Gaya 1977 ).
Daschner found the combination of cefazolin and tobramycin highly active in vitro against Klebsiella pneumonice, especially where the strains had a low sensitivity to the individual antibiotics.
In our own investigations with 50 strains of Klebsiella we found synergism when using a cefazolin/sisomicin combination in 47, and when using cefazolin and gentamicin in 36. Combinations of cefazolin and tobramycin or amikacin were less active (Schassan 1976 (Schassan , 1977 . In our experience, too, the best potentiation was obtained with organisms in the nearly sensitive to moderately resistant range.
From the present studies, it appears that infections with highly sensitive bacteria such as Staph. aureus, E. coli, htmolytic Streptococci. Hwmophilus influenza, and Proteus mirabilis are likely to Cefuroxime 
